{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Nov 10, 2022

Cascades reports third-quarter loss, sales up from year ago

Bill Harris discusses Cascades

VIDEO SIGN OUT

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

 

Cascades Inc. reported a loss in its latest quarter compared with a profit a year ago as its sales rose.

The company says it net loss attributable to shareholders amounted to $2 million or two cents per diluted share for the quarter ended Sept. 30.

The result compared with a profit of $32 million or 32 cents per diluted share a year earlier.

Sales totalled $1.17 billion, up from $1.03 billion in the same quarter last year.

On an adjusted basis, Cascades says it earned 20 cents per share in its latest quarter compared with an adjusted loss of a penny per share in the same quarter last year.

Cascades CEO Mario Plourde says the company's third-quarter performance was in line with expectations notwithstanding the fact that its tissue segment continued to face unprecedented cost inflation and reduced productivity due to labour scarcity and inefficiencies.